Status:
COMPLETED
RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population
Lead Sponsor:
Abbott Medical Devices
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient is implanted with a CRM device
- Patient has no documented history of AF (3 months prior to enrollment)
- Patient is \>18 years of age
- Patient has life expectancy of \>24 months
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
5379 Patients enrolled
Trial Details
Trial ID
NCT00837798
Start Date
October 1 2006
End Date
April 1 2012
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Jude Medical
Sylmar, California, United States, 91342